rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
ClinGen's RASopathy Expert Panel consensus methods for variant interpretation.
|
29493581 |
2018 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Functional specificity of ras isoforms: so similar but so different.
|
21779495 |
2011 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Role of the switch II region in the conformational transition of activation of Ha-ras-p21.
|
10716188 |
2000 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
rac, a novel ras-related family of proteins that are botulinum toxin substrates.
|
2674130 |
1989 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
The ras gene family and human carcinogenesis.
|
3283542 |
1988 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
ras genes.
|
3304147 |
1987 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells.
|
3004741 |
1986 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses.
|
6288698 |
1982 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus.
|
6287572 |
1982 |
rs727503093
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
Nucleotide sequence of the oncogene encoding the p21 transforming protein of Kirsten murine sarcoma virus.
|
6287573 |
1982 |
rs35613389
|
|
CG |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs398122808
|
|
ACCT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs398122809
|
|
CTCT |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs587777239
|
|
GGTCCCGCATGGCGCTGTACTC |
0.700 |
CausalMutation |
CLINVAR |
|
|
|
rs727504747
|
|
AG |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs121917756
|
|
|
0.710 |
GeneticVariation |
UNIPROT |
Two disease-associated mutations, G12V and G12S, have previously been observed in patients with Costello syndrome (CS), and two other mutations, E63K and Q22K, are novel.
|
17412879 |
2007 |
rs727503094
|
|
TT |
0.750 |
GeneticVariation |
CLINVAR |
In the current study, we identified four mutations (p.G12S, p.G12A, p.G12C and p.G12D) in 21 patients and analyzed the associated clinical manifestations of CS in these individuals.
|
21850009 |
2011 |
rs727503094
|
|
TT |
0.750 |
GeneticVariation |
CLINVAR |
Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases.
|
16443854 |
2006 |
rs121917759
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
|
25173338 |
2014 |
rs121917759
|
|
A |
0.800 |
GeneticVariation |
CLINVAR |
A structural systems biology approach for quantifying the systemic consequences of missense mutations in proteins.
|
23093928 |
2012 |
rs104894231
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
|
19995790 |
2010 |
rs121917759
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
|
19995790 |
2010 |
rs104894231
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Severe neonatal manifestations of Costello syndrome.
|
18039947 |
2008 |
rs104894231
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype?
|
18247425 |
2008 |
rs121917759
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype?
|
18247425 |
2008 |